Literature DB >> 21484943

The application of nanoparticles in gene therapy and magnetic resonance imaging.

Fernando Herranz1, Elena Almarza, Ignacio Rodríguez, Beatriz Salinas, Yamilka Rosell, Manuel Desco, Jeff W Bulte, Jesús Ruiz-Cabello.   

Abstract

The combination of nanoparticles, gene therapy, and medical imaging has given rise to a new field known as gene theranostics, in which a nanobioconjugate is used to diagnose and treat the disease. The process generally involves binding between a vector carrying the genetic information and a nanoparticle, which provides the signal for imaging. The synthesis of this probe generates a synergic effect, enhancing the efficiency of gene transduction and imaging contrast. We discuss the latest approaches in the synthesis of nanoparticles for magnetic resonance imaging, gene therapy strategies, and their conjugation and in vivo application.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484943      PMCID: PMC3422774          DOI: 10.1002/jemt.20992

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  84 in total

1.  Organic and inorganic nanoparticle hybrids.

Authors:  Nathaniel G Portney; Krishna Singh; Sumit Chaudhary; Giuseppe Destito; Anette Schneemann; Marianne Manchester; Mihrimah Ozkan
Journal:  Langmuir       Date:  2005-03-15       Impact factor: 3.882

2.  Synchronized infection of cell cultures by magnetically controlled virus.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Lipid-gold-nanoparticle hybrid-based gene delivery.

Authors:  Won-Kyu Rhim; Jin-Soo Kim; Jwa-Min Nam
Journal:  Small       Date:  2008-10       Impact factor: 13.281

Review 4.  Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Authors:  Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

Review 5.  Avidin-biotin technology in targeted therapy.

Authors:  Hanna P Lesch; Minna U Kaikkonen; Jere T Pikkarainen; Seppo Ylä-Herttuala
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

6.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

Review 7.  Targeted hyperthermia using metal nanoparticles.

Authors:  Paul Cherukuri; Evan S Glazer; Steven A Curley
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

8.  Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles.

Authors:  Andreas Hofmann; Daniela Wenzel; Ulrich M Becher; Daniel F Freitag; Alexandra M Klein; Dietmar Eberbeck; Maike Schulte; Katrin Zimmermann; Christian Bergemann; Bernhard Gleich; Wilhelm Roell; Thomas Weyh; Lutz Trahms; Georg Nickenig; Bernd K Fleischmann; Alexander Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-31       Impact factor: 11.205

9.  Polymer beacons for luminescence and magnetic resonance imaging of DNA delivery.

Authors:  Joshua M Bryson; Katye M Fichter; Wen-Jang Chu; Jing-Huei Lee; Jing Li; Louis A Madsen; Patrick M McLendon; Theresa M Reineke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

10.  Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement.

Authors:  Alessandro Aiuti; Sergio Vai; Alessandra Mortellaro; Giulia Casorati; Francesca Ficara; Grazia Andolfi; Giuliana Ferrari; Antonella Tabucchi; Filippo Carlucci; Hans D Ochs; Luigi D Notarangelo; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

View more
  7 in total

Review 1.  PET and MR imaging of neuroinflammation in hepatic encephalopathy.

Authors:  Yun Yan Su; Gui Fen Yang; Guang Ming Lu; Shawn Wu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2014-12-17       Impact factor: 3.584

2.  Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies.

Authors:  Humphrey H P Yiu; Mark R Pickard; Cristina I Olariu; Stephen R Williams; Divya M Chari; Matthew J Rosseinsky
Journal:  Pharm Res       Date:  2011-12-02       Impact factor: 4.200

3.  Development of a Hybrid Nanoprobe for Triple-Modality MR/SPECT/Optical Fluorescence Imaging.

Authors:  Renata Madru; Pontus Svenmarker; Christian Ingvar; Freddy Ståhlberg; Stefan-Andersson Engels; Linda Knutsson; Sven-Erik Strand
Journal:  Diagnostics (Basel)       Date:  2014-03-10

Review 4.  Superparamagnetic Nanoparticles for Atherosclerosis Imaging.

Authors:  Fernando Herranz; Beatriz Salinas; Hugo Groult; Juan Pellico; Ana V Lechuga-Vieco; Riju Bhavesh; J Ruiz-Cabello
Journal:  Nanomaterials (Basel)       Date:  2014-06-05       Impact factor: 5.076

Review 5.  Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines.

Authors:  Fahad Albalawi; Mohd Zobir Hussein; Sharida Fakurazi; Mas Jaffri Masarudin
Journal:  Int J Nanomedicine       Date:  2021-01-08

Review 6.  An Update on Graphene-Based Nanomaterials for Neural Growth and Central Nervous System Regeneration.

Authors:  Maria Grazia Tupone; Gloria Panella; Michele d'Angelo; Vanessa Castelli; Giulia Caioni; Mariano Catanesi; Elisabetta Benedetti; Annamaria Cimini
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

7.  Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.

Authors:  Ajay Sharma; Jason T Rodier; Ashish Tandon; Alexander M Klibanov; Rajiv R Mohan
Journal:  Mol Vis       Date:  2012-10-20       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.